This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Vusala Ibrahimova, Ph.D.
Research Scientist at CureVac SE
Speaker

Profile

Vusala Ibrahimova earned her doctorate in Organic and Polymer Chemistry through joint studies at Université catholique de Louvain and Université de Bordeaux. She subsequently completed over three years of postdoctoral research in Nanomedicine at the University of Bordeaux, France. Her diverse expertise encompasses the design of amphiphilic materials for photosensitizer APIs for PDT, the development of lipopeptide conjugates, lipopetosomes formation, smart delivery platforms, T-responsive recombinant peptides for artificial cell studies as well as the synthesis of fluorescent polymers for applications in optoelectronics and cellular imaging. In 2021, Dr. Ibrahimova has pursued her career as a formulation scientist at Cristal Therapeutics in Maastricht, Netherlands. Since 2022, she joined CureVac as a Research Scientist in the Formulation team within the Technology Department, where she applies her expertise in lipid design and LNP formulation development.

Agenda Sessions

  • CureVac's Tailored LNP Platforms for Prophylactic and Therapeutic mRNA Vaccine

    14:30